Total submissions: 2
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Gene |
RCV000254968 | SCV000321498 | uncertain significance | not provided | 2017-01-31 | criteria provided, single submitter | clinical testing | The A846V variant in the CACNA1H gene has not been reported previously as a pathogenic variant nor as a benign variant, to our knowledge. This variant is not observed in large population cohorts (Lek et al., 2016; 1000 Genomes Consortium et al., 2015; Exome Variant Server). The A846V variant is a conservative amino acid substitution, which is not likely to impact secondary protein structure as these residues share similar properties. This substitution occurs at a position that is conserved across species. In silico analysis is inconsistent in its predictions as to whether or not the variant is damaging to the protein structure/function. Based on currently available evidence, we interpret A846V as a variant of unknown significance. |
Labcorp Genetics |
RCV003765566 | SCV004579876 | benign | Idiopathic generalized epilepsy; Hyperaldosteronism, familial, type IV | 2023-03-13 | criteria provided, single submitter | clinical testing |